HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel.

Abstract
The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in Israel (six tertiary-care and 12 community hospitals). The study included 444 episodes of candidaemia (450 patient-specific isolates, 8.5% fluconazole-resistant). Institutional FRC bloodstream infection rates correlated with annual inpatient days, and were strongly associated with the presence and activity of haematology/oncology services. Infection with Candida krusei and fluconazole-resistant Candida glabrata occurred exclusively in hospitals with >600 beds. These findings suggest that empirical antifungal strategies should be tailored to the nosocomial setting.
AuthorsR Ben-Ami, G Rahav, H Elinav, I Kassis, I Shalit, T Gottesman, O Megged, M Weinberger, P Ciobotaro, P Shitrit, G Weber, A Paz, D Miron, I Oren, J Bishara, C Block, N Keller, D P Kontoyiannis, M Giladi, Israeli Candidaemia Study Group
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 19 Issue 8 Pg. 752-6 (Aug 2013) ISSN: 1469-0691 [Electronic] England
PMID23005038 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.
Chemical References
  • Antifungal Agents
  • Fluconazole
Topics
  • Adult
  • Aged
  • Antifungal Agents (pharmacology)
  • Candida (drug effects, isolation & purification)
  • Candida glabrata
  • Candidemia (epidemiology)
  • Cross Infection (epidemiology)
  • Drug Resistance, Fungal
  • Female
  • Fluconazole (pharmacology)
  • Hospitals
  • Humans
  • Israel (epidemiology)
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: